Tech Company Financing Transactions

TARA Biosystems Funding Round

Harris & Harris Group and private investors participated in a $2.3 million Seed funding round for TARA Biosystems. The round was announced on 1/5/2016.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

430 East 29th St. 1015
New York, NY 10016
USA

Phone

Undisclosed

Website

www.tarabiosystems.com

Email Address

[email protected]

Overview

TARA Biosystems, Inc. provides predictive, in vitro human cardiac tissue models for use in drug discovery and safety assessment. TARA's cardiac tissues are produced from human induced pluripotent stem cell-derived cardiomyocytes, matured to an adult-like phenotype, and interrogated to provide direct measures of cardiac functionality, including contractile force.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Misti Ushio

        

Chief Scientific Officer

Michael Graziano

        

VP - Finance

Steven Lesiak

        

VP - R & D

Rooz Sobbi

        

Browse more venture capital transactions:

Prev: 1/5/2016: Vivex Biomedical venture capital transaction
Next: 1/5/2016: Athletigen venture capital transaction

Share this article

About Our Venture Capital Transactions Database

Our team works diligently to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary